Marshall Wace, LLP Haemonetics Corp Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Haemonetics Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 279,997 shares of HAE stock, worth $17.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

279,997

Previous 222,881 25.63%

Holding current value

$17.6 Million

Previous $17.9 Million 22.05%

% of portfolio

0.03%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$71.16 - $93.38 $4.06 Million - $5.33 Million	57,116 Added 25.63%	279,997 $21.9 Million
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $12.9 Million - $16.3 Million	177,989 Added 396.48%	222,881 $17.9 Million
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $2.97 Million - $3.55 Million	-36,503 Reduced 44.85%	44,892 $3.71 Million
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $1.92 Million - $2.31 Million	27,018 Added 49.69%	81,395 $6.95 Million
Q4 2023 Feb 14, 2024	BUY	$80.59 - $92.61 $2.62 Million - $3.01 Million	32,529 Added 148.89%	54,377 $4.65 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $4.2 Million - $4.76 Million	-50,905 Reduced 69.97%	21,848 $1.96 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $5.88 Million - $6.51 Million	72,753 New	72,753 $6.19 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $4.53 Million - $6.55 Million	-103,583 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $5.13 Million - $7.73 Million	103,583 New	103,583 $5.49 Million
Q1 2021 May 17, 2021	SELL	$111.01 - $139.48 $1.16 Million - $1.46 Million	-10,459 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $6.79 Million - $9.17 Million	-76,452 Reduced 87.97%	10,459 $1.24 Million
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $3.69 Million - $4.56 Million	48,779 Added 127.92%	86,911 $7.58 Million
Q2 2020 Aug 13, 2020	BUY	$84.96 - $118.91 $3.24 Million - $4.53 Million	38,132 New	38,132 $3.42 Million
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $266,360 - $436,481	-3,583 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $409,787 - $463,855	3,583 New	3,583 $412,000
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $17.9 Million - $21.1 Million	-152,363 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$81.74 - $120.34 $8.37 Million - $12.3 Million	102,384 Added 204.85%	152,363 $18.3 Million
Q1 2019 May 14, 2019	BUY	$83.25 - $102.12 $4.16 Million - $5.1 Million	49,979 New	49,979 $4.37 Million
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $203,219 - $258,836	-2,259 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$71.53 - $95.75 $53,933 - $72,195	-754 Reduced 25.02%	2,259 $203,000
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $182,949 - $224,197	3,013 New	3,013 $220,000

Others Institutions Holding HAE

# of Institutions

349

Shares Held

55.7M

Call Options Held

600K

Put Options Held

474K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.23B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Haemonetics Corp Transaction History